Amarin Corp Plc (AMRN)

[couldbebetter]

Golf Stud, My concern lies with the lack of a "significant" sales force that
would be capable of translating reimbursements into AMRN revenues. The
way I envision traditional drug launch sales in Europe is that it is a "top down"
approach, where the sales rep or whatever they are called, has many years
worth of experience and personal contacts to create sales. If that is the case,
then Alex Denner should attempt to find a buyer as quickly as is practical.
The balance may be for AMRN to get enough sales accomplished with a
skeletal sales force to demonstrate the potential to BP. ( I wonder if AMRN
were owned by Bayer if they would have issues with getting reimbursements
from Germany.) Of course we don't want the company given away for peanuts,
but we do not want to hold out for the great offer that never comes. With the
experience Pfizer is seeing from its involvement in Canada, I hope they are
extrapolating what they would be able to do if they owned AMRN in England,
the EU, China (working with EddingPharm) & the ROW.